Arbutus, Spring Bank enter HBV trial collaboration
Spring Bank Pharmaceuticals Inc. and Arbutus Biopharma Corp. have entered into a trial collaboration to investigate the co-administration of Spring Bank’s SB9200 and Arbutus' AB423 for hepatitis B.
- Trial Collaborations
- R&D (No Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com